#PedsTID time for virtual case conference @PIDSociety given by Dr. #AhmadHachem mentor @paulksue1 focusing on #EBV and #PTLD in organ transplant recipients - recording will be available pids.org/transplant-imm… 1/10
Many good pearls here - of note, importance of PTLD as a post-transplant complication in pediatric organ transplantation - overall ped SOT 5 yr incidence 3-15% with 5 yr mortality 20-25%. 2/10
@AST_IDCOP guidelines for PTLD, EBV infection and disease in SOT important resource - note any sign/symptom concerning for PTLD should prompt evaluation with tissue biopsy = gold standard onlinelibrary.wiley.com/doi/full/10.11… 3/10
For EBV viremia alone without symptoms in SOT recipient, approach depends on patient risk assessment - if high risk recommend monitoring with pre-emptive therapy strategy. 4/10
Main risk factors for developing PTLD in SOT recipients include 1) developing primary EBV infection post-transplant, 2) high net state of immunosuppression (driven by organ type e.g. intestinal & lung transplant >> others), 3) earlier time post-transplant. 5/10
Across all organ transplant types, pediatric recipients have higher cumulative incidence of PTLD at 1 & 5 years vs. adults. 6/10
Another PTLD risk factor appreciated = high rate of rise of EBV DNAemia (>44,000 copies/ml/week). 7/10
Approaches to pre-emptive therapy in SOT recipients with EBV viremia with goal to prevent development of PTLD - the primary strategies are reduction of immunosuppression and administration of rituximab. 8/10
Importantly, conventional antiviral therapy unlikely to help EBV viremia in SOT. EBV is predominantly in latent infectious cycle, rather than lytic. Antivirals interrupt replication & thus affect lytic phase virus that is actively replicating, not latent. 9/10
With recognition of high risk scenario for PTLD, early detection of EBV DNAemia via monitoring, pre-emptive reduction in immunosuppression vs. rituximab depending on scenario, there is opportunity to interrupt progression to PTLD with favorable outcome. 9/10

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Rachel Wattier

Rachel Wattier Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @RachelWattier

Oct 22, 2020
High yield talk by Pablo Sanchez at #IDWeek2020 session Antimicrobial Stewardship in Pediatric ICUs excellent bundle for #NICU #antibioticstewardship @eerogersmd @PfaffMd excellent work highlighted by @InfectiousNeo @PedsPharmD
Great summary of the harms of broad spectrum antibiotics in #NICU - greeter risk with cephalosporin > aminoglycoside-based therapy
Each additional day adds risk and combined with what we know from @PedsPharmD oral abstract on Global PPS there is a lot of variability in duration - big opportunity to standardize & shorten
Read 4 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us on Twitter!

:(